Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för John H Weiland. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att John H Weiland har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| Director | 8 947 | |
| US:CAH / Cardinal Health, Inc. | Director | 11 138 |
| US:CELG / Celgene Corp. | Director | 0 |
| US:WST / West Pharmaceutical Services, Inc. | Director | 24 628 |
| US:BCR / C. R. Bard, Inc. - Corporate Bond/Note | Vice Chairman, Pres. and COO, Director | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av John H Weiland. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av John H Weiland som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 |
|
4 | SOLV |
Solventum Corp
Common Stock |
M - Exercise | 3 403 | 8 947 | 61,38 | ||||
| 2026-03-30 |
|
4 | SOLV |
Solventum Corp
Common Stock |
M - Exercise | 1 980 | 5 544 | 55,56 | ||||
| 2025-05-15 |
|
4 | SOLV |
Solventum Corp
Common Stock |
M - Exercise | 3 564 | 3 564 | |||||
| 2021-11-15 |
|
4 | CAH |
CARDINAL HEALTH INC
Common Shares |
A - Award | 3 709 | 11 138 | 49,93 | ||||
| 2020-11-10 |
|
4 | CAH |
CARDINAL HEALTH INC
Common Shares |
A - Award | 3 339 | 7 429 | 81,64 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | −4 756 | 0 | −100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | −1 454 | 0 | −100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −13 266 | 0 | −100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −10 000 | 0 | −100,00 | ||||
| 2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
D - Sale to Issuer | −5 575 | 0 | −100,00 | ||||
| 2019-11-13 |
|
4 | CAH |
CARDINAL HEALTH INC
Common Shares |
A - Award | 3 424 | 4 090 | 514,11 | ||||
| 2019-09-17 |
|
4 | CAH |
CARDINAL HEALTH INC
Common Shares |
A - Award | 666 | 666 | |||||
| 2019-06-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 4 756 | 4 756 | |||||
| 2018-08-07 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
P - Purchase | 5 575 | 5 575 | 89,73 | 500 250 | 500 250 | ||
| 2018-08-01 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 261 | 24 628 | 1,07 | 99,16 | 25 839 | 2 442 066 | |
| 2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 1 454 | 1 454 | |||||
| 2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 13 266 | 13 266 | |||||
| 2018-05-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 1 824 | 45 359 | 4,19 | ||||
| 2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
D - Sale to Issuer | −23 088 | 0 | −100,00 | ||||
| 2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
D - Sale to Issuer | −11 145 | 0 | −100,00 | ||||
| 2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
D - Sale to Issuer | −32 022 | 0 | −100,00 | ||||
| 2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
D - Sale to Issuer | −29 855 | 0 | −100,00 | ||||
| 2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
D - Sale to Issuer | −6 018 | 0 | −100,00 | ||||
| 2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
D - Sale to Issuer | −37 129 | 0 | −100,00 | ||||
| 2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
D - Sale to Issuer | −29 823 | 37 129 | −44,54 | ||||
| 2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
D - Sale to Issuer | −17 025 | 66 952 | −20,27 | ||||
| 2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
D - Sale to Issuer | −0 | 83 977 | 0,00 | ||||
| 2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 11 258 | 83 977 | 15,48 | ||||
| 2018-01-03 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 29 823 | 72 719 | 69,52 | ||||
| 2017-11-09 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −33 435 | 11 145 | −75,00 | ||||
| 2017-11-09 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | −33 435 | 42 896 | −43,80 | 333,31 | −11 144 203 | 14 297 741 | |
| 2017-11-09 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | 33 435 | 76 331 | 77,94 | 136,37 | 4 559 531 | 10 409 298 | |
| 2017-10-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 234 | 24 367 | 0,97 | 96,33 | 22 500 | 2 347 269 | |
| 2017-07-05 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 238 | 24 097 | 1,00 | 94,39 | 22 500 | 2 274 555 | |
| 2017-05-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 1 697 | 43 412 | 4,07 | ||||
| 2017-04-04 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 275 | 23 826 | 1,17 | 81,69 | 22 500 | 1 946 355 | |
| 2017-02-15 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −14 091 | 42 896 | −24,73 | 240,49 | −3 388 809 | 10 316 326 |
| 2017-02-15 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −5 382 | 56 987 | −8,63 | 240,47 | −1 294 210 | 13 703 734 | |
| 2017-02-15 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −5 335 | 62 369 | −7,88 | 240,47 | −1 282 907 | 14 997 943 | |
| 2017-02-15 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −1 055 | 68 978 | −1,51 | 240,47 | −253 696 | 16 587 209 | |
| 2017-02-14 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −1 274 | 68 759 | −1,82 | 240,00 | −305 758 | 16 502 126 |
| 2017-02-14 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −1 098 | 70 033 | −1,54 | 239,92 | −263 438 | 16 802 737 | |
| 2017-02-10 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −14 081 | 71 131 | −16,52 | 239,54 | −3 372 936 | 17 038 654 |
| 2017-02-10 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −200 | 85 212 | −0,23 | 239,98 | −47 996 | 20 449 245 |
| 2017-02-10 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −11 136 | 85 412 | −11,53 | 236,68 | −2 635 668 | 20 215 381 | |
| 2017-02-10 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 1 844 | 96 548 | 1,95 | 164,84 | 303 970 | 15 915 310 | |
| 2017-02-10 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 4 303 | 94 704 | 4,76 | 235,49 | 1 013 313 | 22 301 913 | |
| 2017-02-10 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 6 788 | 90 401 | 8,12 | ||||
| 2017-02-10 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 22 023 | 83 613 | 35,76 | ||||
| 2017-01-04 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 264 | 23 515 | 1,14 | 85,20 | 22 500 | 2 003 439 | |
| 2016-12-16 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
A - Award | 23 088 | 23 088 | |||||
| 2016-12-14 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −11 190 | 0 | −100,00 | ||||
| 2016-12-14 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −7 418 | 61 590 | −10,75 | 219,67 | −1 629 496 | 13 529 410 |
| 2016-12-14 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −2 422 | 69 008 | −3,39 | 220,35 | −533 691 | 15 206 073 |
| 2016-12-14 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −1 000 | 71 430 | −1,38 | 218,82 | −218 824 | 15 630 669 |
| 2016-12-14 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −350 | 72 430 | −0,48 | 217,28 | −76 046 | 15 737 342 |
| 2016-12-14 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | X | 11 190 | 72 780 | 18,17 | 97,68 | 1 093 095 | 7 109 543 |
| 2016-10-04 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 304 | 23 176 | 1,33 | 74,12 | 22 500 | 1 717 815 | |
| 2016-07-05 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 311 | 22 873 | 1,38 | 75,06 | 23 333 | 1 716 815 | |
| 2016-05-05 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 2 262 | 41 450 | 5,77 | ||||
| 2016-04-04 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 363 | 22 523 | 1,64 | 68,91 | 25 000 | 1 552 063 | |
| 2016-02-18 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −1 618 | 61 590 | −2,56 | 187,45 | −303 301 | 11 545 346 |
| 2016-02-18 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −1 395 | 63 208 | −2,16 | 186,25 | −259 819 | 11 772 544 | |
| 2016-02-16 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −648 | 64 603 | −0,99 | 183,35 | −118 808 | 11 844 761 |
| 2016-02-16 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −576 | 65 251 | −0,88 | 182,25 | −104 977 | 11 892 113 |
| 2016-02-16 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −7 837 | 65 827 | −10,64 | 182,16 | −1 427 611 | 11 991 290 |
| 2016-02-16 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −4 312 | 73 664 | −5,53 | 184,08 | −793 768 | 13 560 373 |
| 2016-02-16 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −2 154 | 77 976 | −2,69 | 182,88 | −393 929 | 14 260 499 |
| 2016-02-16 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −1 055 | 80 130 | −1,30 | 183,41 | −193 498 | 14 696 696 | |
| 2016-02-16 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −105 | 81 185 | −0,13 | 184,68 | −19 392 | 14 993 608 |
| 2016-02-12 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −12 411 | 81 290 | −13,25 | 184,88 | −2 294 608 | 15 029 355 | |
| 2016-02-12 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 2 718 | 93 701 | 2,99 | 120,53 | 327 590 | 11 293 442 | |
| 2016-02-12 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 6 341 | 90 983 | 7,49 | 172,18 | 1 091 793 | 15 665 503 | |
| 2016-02-12 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 9 489 | 84 642 | 12,63 | ||||
| 2016-02-12 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 22 075 | 75 153 | 41,59 | ||||
| 2016-02-10 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −5 991 | 53 078 | −10,14 | 180,69 | −1 082 532 | 9 590 875 |
| 2016-02-10 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −2 208 | 59 069 | −3,60 | 181,78 | −401 363 | 10 737 421 |
| 2016-02-10 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −699 | 61 277 | −1,13 | 182,48 | −127 551 | 11 181 684 |
| 2016-02-10 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −5 433 | 61 976 | −8,06 | 179,80 | −976 881 | 11 143 647 | |
| 2016-01-08 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 327 | 22 113 | 1,50 | 61,07 | 20 000 | 1 350 463 | |
| 2015-12-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −2 741 | 67 409 | −3,91 | 189,50 | −519 428 | 12 774 263 |
| 2015-12-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −1 687 | 70 150 | −2,35 | 191,61 | −323 246 | 13 441 483 |
| 2015-12-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −1 668 | 71 837 | −2,27 | 190,30 | −317 419 | 13 670 593 |
| 2015-12-17 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −13 590 | 0 | −100,00 | ||||
| 2015-12-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −9 339 | 73 505 | −11,27 | 187,79 | −1 753 776 | 13 803 603 |
| 2015-12-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −3 551 | 82 844 | −4,11 | 187,12 | −664 449 | 15 501 492 |
| 2015-12-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −700 | 86 395 | −0,80 | 188,88 | −132 218 | 16 318 593 |
| 2015-12-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | X | 13 590 | 87 095 | 18,49 | 84,58 | 1 149 374 | 7 366 084 |
| 2015-12-16 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −33 569 | 11 190 | −75,00 | ||||
| 2015-12-16 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −19 721 | 73 505 | −21,15 | 184,12 | −3 631 074 | 13 533 956 |
| 2015-12-16 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −8 606 | 93 226 | −8,45 | 185,09 | −1 592 876 | 17 255 161 |
| 2015-12-16 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −5 904 | 101 832 | −5,48 | 184,56 | −1 089 613 | 18 793 658 | |
| 2015-12-16 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −5 242 | 107 736 | −4,64 | 183,34 | −961 080 | 19 752 608 |
| 2015-12-16 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | X | 33 569 | 112 978 | 42,27 | 97,68 | 3 279 188 | 11 036 284 |
| 2015-12-11 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
A - Award | 29 855 | 29 855 | |||||
| 2015-10-05 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 365 | 21 744 | 1,71 | 54,83 | 20 000 | 1 192 197 | |
| 2015-07-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 516 | 21 340 | 2,48 | 58,13 | 30 000 | 1 240 497 | |
| 2015-05-07 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 2 448 | 38 883 | 6,72 | ||||
| 2015-04-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 335 | 20 736 | 1,64 | 59,66 | 20 000 | 1 237 115 | |
| 2015-02-20 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −8 413 | 79 409 | −9,58 | 174,99 | −1 472 211 | 13 896 022 |
| 2015-02-18 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −13 616 | 87 822 | −13,42 | 174,51 | −2 376 180 | 15 326 202 |
| 2015-02-18 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −7 630 | 101 438 | −7,00 | 174,92 | −1 334 640 | 17 743 586 | |
| 2015-02-18 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −1 483 | 109 068 | −1,34 | 174,59 | −258 917 | 19 042 233 | |
| 2015-02-13 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −10 110 | 110 551 | −8,38 | 173,80 | −1 757 169 | 19 214 367 | |
| 2015-02-13 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 3 126 | 120 661 | 2,66 | 101,30 | 316 676 | 12 223 471 | |
| 2015-02-13 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 7 294 | 117 535 | 6,62 | 144,72 | 1 055 588 | 17 009 707 | |
| 2015-02-13 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 9 117 | 110 241 | 9,02 | ||||
| 2015-02-13 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 17 638 | 101 124 | 21,13 | ||||
| 2015-01-05 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 372 | 20 401 | 1,85 | ||||
| 2014-12-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −5 916 | 83 486 | −6,62 | 167,44 | −990 573 | 13 978 911 |
| 2014-12-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −3 457 | 89 402 | −3,72 | 166,23 | −574 663 | 14 861 504 |
| 2014-12-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −131 | 92 859 | −0,14 | 167,92 | −21 997 | 15 592 765 |
| 2014-12-17 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −13 589 | 13 590 | −50,00 | ||||
| 2014-12-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −9 206 | 92 990 | −9,01 | 166,63 | −1 533 996 | 15 494 972 | |
| 2014-12-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −7 208 | 102 196 | −6,59 | 166,27 | −1 198 442 | 16 991 727 |
| 2014-12-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −2 810 | 109 404 | −2,50 | 167,30 | −470 107 | 18 303 119 |
| 2014-12-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −1 821 | 112 214 | −1,60 | 167,96 | −305 862 | 18 847 916 |
| 2014-12-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −1 750 | 114 035 | −1,51 | 165,10 | −288 930 | 18 827 557 |
| 2014-12-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | X | 13 589 | 115 785 | 13,30 | 84,58 | 1 149 290 | 9 792 541 |
| 2014-12-12 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
A - Award | 32 022 | 32 022 | |||||
| 2014-12-10 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −6 350 | 102 196 | −5,85 | 170,32 | −1 081 508 | 17 405 684 |
| 2014-12-10 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −6 150 | 108 546 | −5,36 | 173,20 | −1 065 149 | 18 799 675 | |
| 2014-10-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 445 | 19 986 | 2,28 | ||||
| 2014-09-11 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −27 179 | 27 179 | −50,00 | ||||
| 2014-09-11 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −27 179 | 114 696 | −19,16 | 149,50 | −4 063 260 | 17 147 095 |
| 2014-09-11 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | X | 27 179 | 141 875 | 23,70 | 84,58 | 2 298 664 | 11 999 103 |
| 2014-07-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 476 | 19 493 | 2,50 | 42,02 | 20 000 | 819 095 | |
| 2014-05-08 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 3 016 | 36 110 | 9,11 | ||||
| 2014-04-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 464 | 18 969 | 2,51 | ||||
| 2014-02-18 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −69 893 | 0 | −100,00 | ||||
| 2014-02-18 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −59 205 | 114 696 | −34,05 | 138,60 | −8 205 671 | 15 896 631 |
| 2014-02-18 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −12 218 | 173 901 | −6,56 | 139,12 | −1 699 741 | 24 192 765 |
| 2014-02-18 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | X | 69 893 | 186 119 | 60,14 | 86,14 | 6 020 932 | 16 033 246 |
| 2014-02-18 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −1 963 | 69 893 | −2,73 | ||||
| 2014-02-18 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −1 963 | 116 226 | −1,66 | 138,01 | −270 916 | 16 040 530 |
| 2014-02-18 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −1 483 | 118 189 | −1,24 | 136,80 | −202 867 | 16 167 704 | |
| 2014-02-18 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | X | 1 963 | 119 672 | 1,67 | 86,14 | 169 103 | 10 309 169 |
| 2014-02-14 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 3 451 | 127 198 | 2,79 | 75,88 | 261 872 | 9 652 188 | |
| 2014-02-14 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 8 052 | 123 747 | 6,96 | 108,40 | 872 877 | 13 414 825 | |
| 2014-02-12 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −9 328 | 115 695 | −7,46 | 135,32 | −1 262 228 | 15 655 424 |
| 2014-02-12 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −8 460 | 125 023 | −6,34 | 131,78 | −1 114 859 | 16 475 569 | |
| 2014-01-17 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −80 900 | 0 | −100,00 | ||||
| 2014-01-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −80 900 | 133 483 | −37,74 | 136,13 | −11 012 707 | 18 170 733 |
| 2014-01-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | X | 80 900 | 214 383 | 60,61 | 88,76 | 7 180 280 | 19 027 589 |
| 2014-01-17 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −600 | 80 900 | −0,74 | ||||
| 2014-01-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −600 | 133 483 | −0,45 | 136,00 | −81 600 | 18 153 727 |
| 2014-01-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | X | 600 | 134 083 | 0,45 | 88,76 | 53 253 | 11 900 562 |
| 2014-01-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 408 | 18 468 | 2,26 | ||||
| 2013-12-13 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
A - Award | 44 580 | 44 580 | |||||
| 2013-12-13 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 9 489 | 133 483 | 7,65 | ||||
| 2013-12-11 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −8 489 | 123 994 | −6,41 | 137,16 | −1 164 364 | 17 007 243 |
| 2013-12-11 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −1 900 | 132 483 | −1,41 | 137,90 | −262 001 | 18 268 823 |
| 2013-12-11 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −10 062 | 134 383 | −6,97 | 137,68 | −1 385 336 | 18 501 891 | |
| 2013-10-24 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −60 210 | 0 | −100,00 | ||||
| 2013-10-24 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −44 700 | 144 445 | −23,63 | 134,24 | −6 000 354 | 19 389 772 |
| 2013-10-24 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −9 278 | 189 145 | −4,68 | 133,19 | −1 235 736 | 25 192 242 |
| 2013-10-24 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −3 732 | 198 423 | −1,85 | 134,76 | −502 915 | 26 739 027 |
| 2013-10-24 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −2 500 | 202 155 | −1,22 | 131,83 | −329 580 | 26 650 556 |
| 2013-10-24 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | X | 60 210 | 204 655 | 41,68 | 81,70 | 4 918 856 | 16 719 314 |
| 2013-10-22 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −81 164 | 0 | −100,00 | ||||
| 2013-10-22 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −75 918 | 144 445 | −34,45 | 125,61 | −9 536 197 | 18 144 033 |
| 2013-10-22 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −5 246 | 220 363 | −2,33 | 126,08 | −661 398 | 27 782 654 |
| 2013-10-22 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | X | 81 164 | 225 609 | 56,19 | 83,47 | 6 775 003 | 18 832 284 |
| 2013-10-22 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −3 361 | 81 164 | −3,98 | ||||
| 2013-10-22 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −3 361 | 144 445 | −2,27 | 125,01 | −420 165 | 18 057 366 |
| 2013-10-22 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | X | 3 361 | 147 806 | 2,33 | 83,47 | 280 553 | 12 337 834 |
| 2013-10-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 491 | 18 022 | 2,80 | ||||
| 2013-08-14 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −5 537 | 144 445 | −3,69 | 116,16 | −643 176 | 16 778 722 |
| 2013-08-14 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −5 363 | 149 982 | −3,45 | 116,84 | −626 586 | 17 523 181 | |
| 2013-08-02 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −49 359 | 0 | −100,00 | ||||
| 2013-08-02 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −49 359 | 155 345 | −24,11 | 115,55 | −5 703 294 | 17 949 713 |
| 2013-08-02 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | X | 49 359 | 204 704 | 31,77 | 73,99 | 3 652 072 | 15 146 070 |
| 2013-08-02 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −37 977 | 49 359 | −43,48 | ||||
| 2013-08-02 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −37 977 | 155 345 | −19,64 | 115,10 | −4 371 267 | 17 880 709 |
| 2013-08-02 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | X | 37 977 | 193 322 | 24,45 | 73,99 | 2 809 918 | 14 303 916 |
| 2013-07-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 284 | 8 744 | 3,36 | ||||
| 2013-05-09 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 2 003 | 16 393 | 13,92 | ||||
| 2013-04-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 308 | 8 435 | 3,80 | ||||
| 2013-03-11 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −10 800 | 155 345 | −6,50 | 99,52 | −1 074 827 | 15 460 119 |
| 2013-02-15 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −1 456 | 166 145 | −0,87 | 101,46 | −147 718 | 16 856 270 | |
| 2013-02-15 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 3 586 | 167 601 | 2,19 | 71,02 | 254 671 | 11 902 708 | |
| 2013-02-15 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 8 367 | 164 015 | 5,38 | 101,46 | 848 874 | 16 640 171 | |
| 2013-02-15 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 12 052 | 155 648 | 8,39 | ||||
| 2013-02-13 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −5 445 | 164 765 | −3,20 | 101,10 | −550 517 | 16 658 595 | |
| 2013-01-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 369 | 8 101 | 4,77 | ||||
| 2012-12-14 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
A - Award | 44 759 | 44 759 | |||||
| 2012-12-14 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 9 117 | 170 210 | 5,66 | ||||
| 2012-10-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 271 | 7 705 | 3,65 | ||||
| 2012-08-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −12 057 | 161 093 | −6,96 | 98,38 | −1 186 111 | 15 847 601 |
| 2012-08-17 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −3 497 | 173 150 | −1,98 | 98,59 | −344 785 | 17 071 684 |
| 2012-08-15 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −10 263 | 176 647 | −5,49 | 98,37 | −1 009 571 | 17 376 794 | |
| 2012-07-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 267 | 7 407 | 3,74 | ||||
| 2012-05-09 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −70 406 | 0 | −100,00 | ||||
| 2012-05-09 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −70 406 | 186 910 | −27,36 | 100,13 | −7 050 034 | 18 716 075 |
| 2012-05-09 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | X | 70 406 | 257 316 | 37,67 | 66,80 | 4 702 769 | 17 187 442 |
| 2012-05-09 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −3 400 | 70 406 | −4,61 | ||||
| 2012-05-09 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −3 400 | 186 910 | −1,79 | 100,01 | −340 038 | 18 693 122 |
| 2012-05-09 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | X | 3 400 | 190 310 | 1,82 | 66,80 | 227 103 | 12 711 776 |
| 2012-05-04 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −6 522 | 73 806 | −8,12 | ||||
| 2012-05-04 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −6 522 | 186 910 | −3,37 | 100,03 | −652 380 | 18 696 188 |
| 2012-05-04 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | X | 6 522 | 193 432 | 3,49 | 66,80 | 435 637 | 12 920 310 |
| 2012-05-03 |
|
4 | BCR |
BARD C R INC /NJ/
Option (Right to Buy) |
M - Exercise | −7 447 | 80 328 | −8,48 | ||||
| 2012-05-03 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −7 447 | 186 910 | −3,83 | 100,01 | −744 755 | 18 692 412 |
| 2012-05-03 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
M - Exercise | X | 7 447 | 194 357 | 3,98 | 66,80 | 497 422 | 12 982 095 |
| 2012-05-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Common Stock |
A - Award | 2 459 | 14 194 | 20,95 | ||||
| 2012-04-02 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 360 | 7 111 | 5,33 | ||||
| 2012-03-05 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −8 789 | 186 910 | −4,49 | 92,91 | −816 624 | 17 366 639 |
| 2012-03-05 |
|
4 | BCR |
BARD C R INC /NJ/
Restricted Stock Units |
A - Award | 12 111 | 12 111 | |||||
| 2012-02-14 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
F - Taxes | −6 547 | 195 699 | −3,24 | 95,96 | −628 217 | 18 778 325 | |
| 2012-02-10 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 4 299 | 202 246 | 2,17 | 65,18 | 280 196 | 13 181 806 | |
| 2012-02-10 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
A - Award | 10 032 | 197 947 | 5,34 | 93,11 | 934 080 | 18 430 872 | |
| 2012-01-03 |
|
4 | WST |
WEST PHARMACEUTICAL SERVICES INC
Phantom Stock Unit |
A - Award | 484 | 6 722 | 7,77 | 37,93 | 18 375 | 254 965 | |
| 2010-08-11 |
|
4 | BCR |
BARD C R INC /NJ/
Common Stock |
S - Sale | X | −14 433 | 162 825 | −8,14 | 80,70 | −1 164 739 | 13 139 952 |
| 2004-02-13 |
|
4 | bcr |
BARD C R INC /NJ/
Common Stock |
A - Award | 4 074 | 79 211 | 5,42 | 49,53 | 201 777 | 3 923 162 | |
| 2004-02-13 |
|
4 | bcr |
BARD C R INC /NJ/
Common Stock |
A - Award | 9 505 | 75 137 | 14,48 | 93,16 | 885 486 | 6 999 763 | |
| 2004-02-13 |
|
4 | bcr |
BARD C R INC /NJ/
Common Stock |
A - Award | 12 500 | 65 632 | 23,53 |